Biodesix Inc (BDSX)
1.57
0.00 (0.00%)
USD |
NASDAQ |
May 20, 16:00
1.56
-0.01
(-0.64%)
After-Hours: 20:00
Biodesix Gross Profit Margin (Quarterly): 78.57% for March 31, 2024
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
Date | Value |
---|---|
March 31, 2024 | 78.57% |
December 31, 2023 | 77.00% |
September 30, 2023 | 76.07% |
June 30, 2023 | 72.73% |
March 31, 2023 | 65.01% |
December 31, 2022 | 65.59% |
September 30, 2022 | 67.29% |
June 30, 2022 | 63.65% |
March 31, 2022 | 50.60% |
December 31, 2021 | 65.49% |
Date | Value |
---|---|
September 30, 2021 | 58.32% |
June 30, 2021 | 40.39% |
March 31, 2021 | 36.89% |
December 31, 2020 | 45.79% |
September 30, 2020 | 57.67% |
June 30, 2020 | 55.79% |
March 31, 2020 | 68.98% |
December 31, 2019 | 77.87% |
September 30, 2019 | 61.87% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
36.89%
Minimum
Mar 2021
78.57%
Maximum
Mar 2024
62.40%
Average
65.01%
Median
Mar 2023
Gross Profit Margin (Quarterly) Benchmarks
Fonar Corp | 45.70% |
XWELL Inc | 30.61% |
ProPhase Labs Inc | -11.92% |
Applied DNA Sciences Inc | 31.80% |
Veracyte Inc | 67.51% |
Gross Profit Margin (Quarterly) Related Metrics
Return on Assets | -54.53% |
Return on Invested Capital | -167.0% |
Profit Margin (Quarterly) | -91.87% |
Operating Margin (Quarterly) | -73.92% |
Return on Net Operating Assets | -86.05% |